Median progression-free survival (PFS) and overall survival (OS) were generally shorter in SDLN-positive patients, although in some studies (e.g., Braun et al., Park et al.), survival times were similar between groups and did not reach statistical significance, with the exception of Bats et al.
← all excerpts
Prognostic and predictive value of supradiaphragmatic lymph node involvement detected by 18F-FDG PET/CT in advanced ovarian cancer: a systematic review and meta-analysis.
1
—
—